Advertisement

Topics

Peptimmune,Inc Company Profile

14:20 EDT 19th June 2018 | BioPortfolio

Peptimmune's metabolic disease expertise is based upon polymer chemistry technologyand related ntellectual property assets. Peptimmune is using non-absorbable hydrogelpolymers as fat binding agents to improve the tolerability of lipase inhibitors for thetreatment of obesity. The polymer technology utilizes a proprietary polymer thateliminates fat coalescence. A drug candidate has been identified which acts withinthe GI tract to inhibit pancreatic lipase and thereby prevent fat digestion, and isexpected to result in fat excretion without undesirable side effects.GT 389-255 is a novel conjugate of a proprietary pancreatic lipase inhibitor and a fatbinding hydrogel polymer for the treatment of obesity. It is expected to block fat
absorption with fewer side effects than currently marketed lipase inhibitors. Phase Iclinical trials were initiated in August 2004.

Location

64 Sidney St,Suite 380
Cambridge
Massachusetts
02139
United States of America

Contact

Phone: 617.715.8000
Fax: 617.661.8855
Email: info@peptimmune.com


News Articles [0 Results]

None

Drugs and Medications [0 Results]

None

PubMed Articles [0 Results]

None

Clinical Trials [0 Results]

None

Companies [2 Associated Companies listed on BioPortfolio]

Peptimmune,Inc

Peptimmune's metabolic disease expertise is based upon polymer chemistry technologyand related ntellectual property assets. Peptimmune is using non-absorbable hydrogelpolymers as fat binding agents to...

Peptimmune, Inc.

Peptimmune, Inc. is a privately held clinical stage biotechnology company focused on the development of peptide therapies to improve the management of chronic autoimmune and inflammatory disorders. Th...

More Information about "Peptimmune,Inc" on BioPortfolio

We have published hundreds of Peptimmune,Inc news stories on BioPortfolio along with dozens of Peptimmune,Inc Clinical Trials and PubMed Articles about Peptimmune,Inc for you to read. In addition to the medical data, news and clinical trials, BioPortfolio also has a large collection of Peptimmune,Inc Companies in our database. You can also find out about relevant Peptimmune,Inc Drugs and Medications on this site too.

Advertisement
Quick Search
Advertisement
Advertisement

 

Relevant Topics

Obesity
Obesity is the condition in which excess fat has accumulated in the body (mostly in subcutaneous tissues). clinical obesity is considered to be present when a person has a BMI of over 30 (Oxford Dictionary of Medicine). It is becoming increasing common i...

Drug Discovery
Clinical Approvals Clinical Trials Drug Approvals Drug Delivery Drug Discovery Generics Drugs Prescription Drugs In the fields of medicine, biotechnology and pharmacology, drug discovery is the process by which drugs are dis...


Corporate Database Quicklinks



Searches Linking to this Company Record